Frontiers in Pharmacology (May 2022)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

  • José Diogo S. Souza,
  • Maíra Fassoni-Ribeiro,
  • Rayssa Miranda Batista,
  • Juliana Mayumi Ushirohira,
  • Antonio W. Zuardi,
  • Antonio W. Zuardi,
  • Francisco S. Guimarães,
  • Francisco S. Guimarães,
  • Alline C. Campos,
  • Flávia de Lima Osório,
  • Flávia de Lima Osório,
  • Daniel Elias,
  • Cacilda S. Souza,
  • AndRea A. Fassoni,
  • Jaime E. C. Hallak,
  • Jaime E. C. Hallak,
  • José Alexandre S. Crippa,
  • José Alexandre S. Crippa

DOI
https://doi.org/10.3389/fphar.2022.881617
Journal volume & issue
Vol. 13

Abstract

Read online

Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although CBD-related rash is described, few case reports are well documented in the literature, and usually, CBD was used concomitantly with other medications. Thus, we report four women who presented a skin rash after ongoing CBD use. Other causes of these skin rashes were ruled out after conducting an extensive viral and serological detection panel, and three patients had their lesions biopsied. Two patients were re-exposed to the vehicle (MCT) without developing a new skin rash. Therefore, clinicians must be aware of this potential adverse effect of CBD use.

Keywords